Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B - Wikidata - wikimedia - TriplyDB

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B

http://www.wikidata.org/entity/Q34033825

about

Improved Efficacy of a Gene Optimised Adenovirus-based Vaccine for Venezuelan Equine Encephalitis Virus Analysis of transcriptome data reveals multifactor constraint on codon usage in Taenia multiceps.Bioinformatics in new generation flavivirus vaccines.Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine Immunomodulator-based enhancement of anti smallpox immune responses.Non-uniqueness of factors constraint on the codon usage in Bombyx mori.Alphavirus replicon approach to promoterless analysis of IRES elements.Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.Optimization and delivery of plasmid DNA for vaccination.DNA vaccines against mycobacterial diseases.DNA immunization.Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.DNA vaccines against tuberculosis DNA vaccines against mycobacterial diseases

P2860

Q27489413-4D0A0633-730D-4496-B462-F17E7A417483 Q33582050-8FBC31F2-BB55-4A13-A57A-8033922A276E Q33839001-80F21D79-8858-46D6-90B5-65B298A1579C Q33850497-3F76F354-2FD1-4369-BFC3-F639D514590D Q35391402-D9FC0B0E-7BA1-4184-8A61-F83500E4F09F Q35576338-9C3C88D6-90C7-4F67-A3E5-E8F65A76664E Q35828303-81829E7B-8743-498C-B904-2706162FE6C6 Q35887146-2B68B31B-D214-4E13-BFD5-3156406764F8 Q36302781-78A8A507-4328-4A43-BE36-D090BC09D0E8 Q36690285-A7D7AE9C-30FE-4C72-92A1-9E6DAECC231A Q36895737-7B608F7F-CD87-44A4-A486-EEEC03C6132A Q37576264-125CF62E-6224-45A8-839E-D587AF5F5CCD Q39320921-2DD45A4E-9F1B-4282-8A29-AF898AED46FC Q40153814-B6A8A36C-E64A-4ABD-B2BD-545950B8C3AD Q41191220-8A06C68E-6A59-4327-AFBA-F41D5185A64D Q55154648-ADAF5332-7611-4E2E-AC73-CDCAF4FB5396 Q55432126-1A32CA29-0DD8-4062-B162-009260A565B9 Q57203104-B5C4CBD8-B661-4973-9ADC-C40C2D412551 Q57203115-CA1E274B-AF1B-43CE-A8DF-B93073062DBD

P2860

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B

http://www.wikidata.org/entity/Q34033825

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@ast

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@en

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@nl

type

label

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@ast

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@en

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@nl

prefLabel

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@ast

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@en

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@nl

P1433

Q34033825-D93B5C37-5DE4-43CC-813A-9F4530F4A63C

P1476

Q34033825-009A0BE2-F40B-4E36-B8B8-1C22D8628870

P2093

Q34033825-3591B9D5-376B-4E7F-845B-176654C974E9

Q34033825-39501FE9-ADC5-4A8C-A115-09523A3FA08E

Q34033825-74325FD5-C1DD-41E8-ACC9-C87F04C853F2

Q34033825-AB2BFBCD-CB23-414F-9F95-5170D6EADE2F

Q34033825-C5E52687-CF9B-433C-80EB-FA80BA94D14B

Q34033825-C9D8292B-80F3-4A62-96AD-5ACF3850D1F5

P2860

Q34033825-05087AD6-A1B4-4C1C-A6DB-E9C4130DEEB2

Q34033825-0B126B90-E0BF-43AD-A91C-82883A8E7EC0

Q34033825-0B16BEBB-FC43-4BBB-A80B-8E1DE305068B

Q34033825-1EB9E1F3-61C4-41F7-A458-BF590EB6846D

Q34033825-1F919C28-58F3-4031-8872-FF5BC8CAA06A

Q34033825-3597724B-00D1-48DF-8C77-C884CFAC78F4

Q34033825-3C50FCDA-2D21-407B-94CD-CA5814EC4899

Q34033825-3E01ED08-0335-4927-BFFC-F8CACC4A2B1B

Q34033825-41D1A46F-DBA2-490C-8CC2-EA06BAF1F50E

Q34033825-44121E89-D8AB-4613-A47E-02E8F70DE331

P304

Q34033825-74EBCEB2-00E9-4E0C-BCDC-C68D1CD2310C

P31

Q34033825-69A633F7-F47D-4305-AEBB-7068CD3475DC

P356

Q34033825-14B63AFA-1E5C-448F-A4D7-2C2539EA7C7A

P407

Q34033825-EE89943D-0FA4-4E5A-BF13-D811805D360E

P433

Q34033825-8B88A621-B3B3-4244-842E-641F63CAD2CA

P478

Q34033825-3F1087AC-17CC-45E8-BCC0-C56BB8A18AF1

P577

Q34033825-2B7E0DAC-F911-428A-9925-FC69503E872A

P698

Q34033825-7DCB2A6D-DEC3-4328-92EE-288375117F6A

P932

Q34033825-3FBA5A12-18BC-4EB0-9DEE-AE6F605B2D64

P356

IAI.73.9.5666-5674.2005

P1433

Infection and Immunity

P1476

Optimization of codon usage en ...... ng mycobacterial antigen Ag85B

@en

P2093

Chang-Yuil Kang

http://www.w3.org/2001/XMLSchema#string

Eun-Gae Lee

http://www.w3.org/2001/XMLSchema#string

Hyun-Jeong Ko

http://www.w3.org/2001/XMLSchema#string

Sang-Nae Cho

http://www.w3.org/2001/XMLSchema#string

Sung-Youl Ko

http://www.w3.org/2001/XMLSchema#string

Yeon-Jeong Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Codon usage tabulated from international DNA sequence databases: status for the year 2000

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

DNA vaccines: improving expression of antigens

DNA vaccines: immunology, application, and optimization*

Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection

Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

P304

5666-5674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.73.9.5666-5674.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16113284

http://www.w3.org/2001/XMLSchema#string

P932

1231050

http://www.w3.org/2001/XMLSchema#string